Article | March 3, 2017

Are Clinical Trial Matching Services Truly Patient-Centric?

Source: Oracle Health Sciences
Are Clinical Trial Matching Services Truly Patient-Centric?

By Craig Morgan, goBalto

If you have ever tried to find the right clinical trial for yourself or a loved one, you know the process can be confusing and challenging. For example, in the age of precision medicine, oncologists often offer multiple treatment options, from FDA approved indications to experimental therapeutics that are not yet on the market. Meanwhile, for sponsors, effective patient recruitment for clinical trials is critical to meeting timelines and budget goals. Recruitment shortfalls for study participants creates a major problem for the pharmaceutical industry by delaying new therapies from reaching the market, estimated to represent a daily loss of $1 – 8 million dollars.i In addition, under enrollment and/or delayed enrollment at investigative sites can compromise a trial's statistical power and scientific validity. And recent research indicates the problem may be getting worse. According to the Tufts Center for the Study of Drug Development (CSDD), clinical trial enrollment rates overall have dropped 20 percent since 2000, with only 2 million volunteers now participating.ii